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Abstract
Background: The results of routine influenza surveillance in 13 regions in the Philippines from 2006 to 2012 are
presented, describing the annual seasonal epidemics of confirmed influenza virus infection, seasonal and alert
thresholds, epidemic curve, and circulating influenza strains.
Methods: Retrospective analysis of Philippine influenza surveillance data from 2006 to 2012 was conducted
to determine seasonality with the use of weekly influenza positivity rates and calculating epidemic curves and
seasonal and alert thresholds using the World Health Organization (WHO) global epidemiological surveillance
standards for influenza.
Results: Increased weekly influenza positive rates were observed from June to November, coinciding with the
rainy season and school opening. Two or more peaks of influenza activity were observed with different dominant
influenza types associated with each peak. A-H1N1, A-H3N2, and two types of B viruses circulated during the
influenza season in varying proportions every year. Increased influenza activity for 2012 occurred 8 weeks late in
week 29, rather than the expected week of rise of cases in week 21 as depicted in the established average
epidemic curve and seasonal threshold. The intensity was severe going above the alert threshold but of short
duration. Southern Hemisphere vaccine strains matched circulating influenza virus for more surveillance years
than Northern Hemisphere vaccine strains.
Conclusions: Influenza seasonality in the Philippines is from June to November. The ideal time to administer
Southern Hemisphere influenza vaccine should be from April to May. With two lineages of influenza B circulating
annually, quadrivalent vaccine might have more impact on influenza control than trivalent vaccine. Establishment
of thresholds and average epidemic curve provide a tool for policy-makers to assess the intensity or severity of
the current influenza epidemic even early in its course, to help plan more precisely resources necessary to control
the outbreak. Influenza surveillance activities should be continued in the Philippines and funding for such
activities should already be incorporated into the Philippine health budget.
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Background
The World Health Organization recommends that sea-
sonal and alert thresholds and average epidemic curves
be established in countries as tools for early detection of
influenza outbreaks to help control annual influenza epi-
demics [1, 2]. Seasonal influenza epidemics occur all
over the world and cause substantial economic burden
through health care costs and absenteeism [3]. Although
surveillance is now routinely conducted in many coun-
tries providing seasonality data and recommendations
for timely vaccination [4, 5], not all countries have estab-
lished influenza thresholds or epidemic curves. Developed
countries like the United States (US), United Kingdom
(UK), most European countries, Australia, and New
Zealand [6–10] are already using thresholds for influenza
surveillance calculated through various methods [11, 12].
In contrast, few countries in Asia have established their
own thresholds and epidemic curves to determine if an
influenza outbreak has started while concurrently moni-
toring influenza activity [2]. The purpose of this article is
to report the results of Philippine National Influenza
Surveillance from 2006 to 2012, particularly on the estab-
lishment of seasonal and alert thresholds, and average
epidemic curve according to methods in the WHO man-
ual [1], define the seasonality of influenza, and describe
the circulating influenza strains.
Methods
Study design
We retrospectively analyzed weekly trends in influ-
enza virus activity using Philippine National Influenza
Surveillance data from 2006 to 2012.
Surveillance site
The Philippines is located within the latitude and longi-
tude of 13° 00′ N, 122° 00′ E [13]. The Philippines in-
cludes 300,000 km2 of total land area and is divided into
three island groups: Luzon, Visayas, and Mindanao. It is
administratively divided into 17 regions. It has a tropical
climate with the rainy season from June to November
and the dry season from December to May [14].
Establishment of influenza sentinel sites
In 2004, the Research Institute for Tropical Medicine
(RITM) became a National Influenza Center (NIC) and
received a grant from the Centers for Disease Control
and Prevention (CDC) in the United States (US), to
establish a National Influenza Surveillance Network.
Surveillance activities started in ten sentinel sites in five
regions in June 2005. From 2006 to October 2008, the
sentinel sites had increased to 36 distributed in 13 out of
17 regions in the country. There were 18 health centers
and 18 Outpatient Departments (OPD) of tertiary hospi-
tals. Eight of the health centers were located in the
National Capital Region (NCR) (Fig. 1). In November
2008, a CDC-funded influenza Burden of Disease study
(BOD) [15] was set up with 16 health centers in the
Cordillera Autonomous Region (CAR) (Fig. 1). The NIC
asked the investigators to contribute influenza virus in-
fection data to the national influenza surveillance. There
were now 52 sentinel sites by 2009. Sentinel sites were
chosen based on the high number of clinic consultations
among the health centers in the city, a high population
density, and the region being a migratory pathway of
birds mixing with local population of fowls and poultry.
Data collection
Clinical and epidemiologic data on influenza-like-illness
Clinical and epidemiologic data were collected in health
centers and outpatient departments or admissions in
hospitals designated as influenza surveillance sites, from
patients with influenza-like-illness (ILI). The health
center is the first line of primary health care in the
Philippines, and is located in the community it is serving
with a typical population of 15,000 to 250,000. One
physician, one nurse, one midwife, one medical tech-
nologist and one sanitary inspector usually man the
health center. It is responsible for the delivery of the
health programs of the Department of Health. These
health services include but are not limited to morbidity
consultations and management, expanded program of
immunization, prenatal care, family planning services
and such disease control programs like tuberculosis, diar-
rhea, and acute respiratory infections. As the first line of
primary health care, sick individuals who patronize the
services at the health centers are either mildly to severely
sick. Severely ill patients consulting the center are imme-
diately referred to the hospitals.
Data collected were written into case report forms and
included signs and symptoms of cough, fever, sore
throat, rhinitis or colds, and history of travel and treat-
ment received for illness before consulting the health
center. ILI was defined as any patient with history of
fever of sudden onset or measured temperature of
>37.7 °C and cough or sore throat [16]. In children
≤3 years of age, ILI was defined only as fever and colds.
“Colds” in these children was synonymous with runny
nose. Sentinel sites were visited twice a week (Monday
and Tuesday) to collect nasopharyngeal (NP) or oropha-
ryngeal (OP) swabs from patients with ILI. Only clinical
information and epidemiologic data were collected from
Wednesday to Friday.
Specimen collection and transport of specimens
A standard operating procedure was created for the col-
lection and transport of appropriate clinical specimens
(NP or OP swabs) from patients with ILI throughout each
year and especially during the influenza season or
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suspected outbreaks. Influenza surveillance officers (ISO)
employed by the project or trained personnel like mid-
wives or nurses in the sentinel sites collected the NP/OP
swabs. Swabs were transferred to virus transport medium
(VTM) and stored in refrigerators before transporting to
RITM in cold boxes with ice or frozen gel packs through
private couriers or by ISO within a day or two of specimen
collection.
Identification of influenza virus
For the ILI sentinel surveillance clinical specimens (NP
or OP swabs), we used viral culture to detect influenza
virus and other respiratory viruses (Parainfluenza 1,2,3,
Respiratory Syncytial Virus (RSV), Herpes Simplex Virus
(HSV), adenovirus, enterovirus and rhinovirus) using
standard procedures recommended by the WHO Global
Influenza Surveillance Network (WHO-GISN) [17]. From
viral culture, direct Immunofluorescence (IF) test of the
Imagen kit was used to identify influenza virus types A
and B. We performed Hemagglutination Inhibition (HAI)
test using the WHO Influenza Reagent kit provided by the
WHO Collaborating Centre for Reference and Research
on Influenza (WHO-CCRI), Melbourne, Australia for
further influenza virus strain characterization. For the
confirmation of Parainfluenza 1, 2, 3, RSV, HSV and
Adenovirus in viral culture, we used Immunofluorescence
test while Acid stability testing was used to identify en-
terovirus and rhinovirus.
The influenza BOD study used real-time reverse-
transcriptase polymerase chain reaction (RT-PCR) to
detect Influenza A from clinical specimens (NP or OP
swabs) using the US CDC method or the Applied
Biosystems Pandemic H1N1/09 Assay Set v. 2.0 (Life
Technologies, CA, USA) [18]. Further subtyping was
done to identify seasonal H1 and H3 subtypes using the
method of the Centre for Health Protection, Department
of Health, Hong Kong SAR [19] and Pandemic H1N1
2009 subtype [18] for Influenza A positive samples.
Conventional RT-PCR methodology was used to detect
Influenza B and RSV [20].
Data management and statistical analysis
The National Influenza Surveillance database containing
information from CRFs that were initially encoded into
EPI-INFO software version 6.04 (public domain statis-
tical software from CDC) was used to obtain data on
weekly counts of ILI cases, ILI cases with and without
specimens, and those that were positive for influenza
Fig. 1 Map of the Philippines showing the sentinel sites (areas with numbers) participating in the national influenza surveillance network. (The
map was created using Epi Info Map of Epi Info 7)
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and other viruses. Analysis was conducted using MS-
Excel, STATA 10 (STATA Corporation, College Station,
TX, USA), and R 2.15.0 software [21]. We calculated sea-
sonal and alert thresholds, and epidemic curves using
both counts (number of influenza positive cases) and pro-
portions (percent positivity rates). We chose to present
the results according to percent positivity rates per week.
Determination of influenza season and seasonal threshold
Seasonal threshold was defined as the level of influenza
activity that signalled the start and end of the annual influ-
enza season [1]. We defined influenza season as the period
in which weekly influenza positive rates were above the
average influenza positivity rate for a particular surveil-
lance year for at least three consecutive weeks. Weekly in-
fluenza positivity rate was the per cent of ILI with
specimens per week, which were positive for influenza
virus. We noted the onset, end, and duration of the influ-
enza season for each surveillance year. The onset of influ-
enza season was the week in which positivity rate was
above the weekly average positivity rate for that year and
which continued for three consecutive weeks. The end of
the influenza season was the first week in which the posi-
tivity rate was below the average weekly positivity rate for
that year and which continued for three consecutive
weeks. Once the onset and end of the influenza season
was known, weekly data from this period were deleted
creating a pre- and post-influenza period. This was done
for surveillance years 2006, 2007, 2008, 2010, and 2011
and the average weekly influenza positivity rate for all
these years was determined and considered as the seasonal
threshold. We excluded 2009 because a pandemic year
would not reflect findings for a regular influenza season.
Determination of average epidemic curve and alert
threshold
We used the weekly influenza positivity rates for the cal-
culation of average epidemic curve and alert threshold
utilizing the 2006, 2007, 2008, 2010 and 2011 data. The
average epidemic curve was the usual level of influenza
activity in and out of season and alert threshold was the
level above which influenza activity was higher than
most years [1]. Using Excel, the transmission peaks of
5 years of data were aligned around the median week of
peak occurrence during the influenza season for each
year studied. Then we calculated the average weekly in-
fluenza positivity rate for each week centered on the me-
dian peak week of transmission. A 4-week running
average was used to smooth the curve that represented
the average epidemic curve. The standard deviation (SD)
of the mean for each week was calculated to define ex-
treme values, after which a curve was created for those
values based on 1.65 SD above the mean representing
the upper 90% confidence interval of the mean. This
value was used as the alert threshold for severe seasons.
After this procedure, weekly data for 2012 was plotted
to the curve to determine how 2012 compared with the
average epidemic curve, seasonal and alert thresholds
calculated from the previous 5 years of observation.
Comparison of circulating influenza viruses with Northern
and Southern Hemisphere vaccine antigens
Comparison was done by simply matching the influenza
viruses by type, subtype and/or lineage (in the case of in-
fluenza B) and by circulating strain for each surveillance
year with the Northern (NH) and Southern Hemisphere
(SH) vaccine antigens recommended for the influenza
seasons for the same surveillance year.
Results
Number of ILI cases enrolled from 2006 to 2011
There were 8826 ILI cases enrolled in 2006. The numbers
steadily increased through the course of surveillance and
in 2011, 18,714 cases were enrolled. The highest number
of ILI case enrolled was during the 2009 pandemic. The
total number of ILI cases from 2006 to 2011 was 102,806.
Mean specimen (NP or OP swabs) collection rate was
55.3% (Range 45.2 to 67.5%). Majority (91%) of patients
with ILI who went to the sentinel sites were children
under 15 years of age (Table 1).















<6 months 624 (7.07) 944 (8.82) 2128 (9.74) 1732 (7.67) 1538 (7.64) 1623 (8.67) 8589 (8.35)
6–23 months 2525 (28.61) 3291 (30.74) 7156 (32.76) 6515 (28.86) 6064 (30.11) 5937 (31.72) 31488 (30.63)
2–4 years 2405 (27.25) 2846 (26.58) 5613 (25.70) 5511 (24.41) 5585 (27.73) 5390 (28.8) 27350 (26.6)
5–14 years 2393 (27.11) 2676 (24.99) 5175 (23.69) 6179 (27.37) 5258 (26.11) 4452 (23.79) 26133 (25.42)
15–49 years 757 (8.58) 746 (6.97) 1504 (6.89) 2269 (10.05) 1479 (7.34) 1110 (5.93) 7865 (7.65)
50+ years 89 (1.01) 113 (1.06) 246 (1.13) 313 (1.39) 198 (0.98) 200 (1.07) 1159 (1.13)
No data 33 (0.37) 91 (0.85) 22 (0.10) 56 (0.25) 18 (0.09) 2 (0.01) 222 (0.22)
Total 8826 10707 21844 22575 20140 18714 102806
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Influenza seasonality and duration
Figure 2 shows the number of influenza virus positive
ILI cases per week, weekly influenza positivity rates, 4-
week moving average, average weekly influenza positivity
rates for each year, and influenza types and subtypes for
surveillance years 2006, 2007, 2008, 2009, 2010 and
2011. Excluding 2009, the pandemic year, the highest
weekly influenza positivity rate was seen in 2010 (35%).
Influenza virus activity was observed all-year round but
with distinct weekly positivity rates above the average
weekly influenza positivity rate for a year starting
between weeks 24 to 31 and ending during weeks 41 to
52 (Table 2).
Table 2 also shows the duration and peak weeks of the
influenza season. The onset of the influenza season was
not very different for the years 2006 to 2010. The end of
influenza season however differed considerably between
the years resulting in variation in the duration of influ-
enza season. The year 2010 was an unusually severe sea-
son. This was also true for 2009 because this was the
pandemic year. The median week of onset for the 5 years
of surveillance, 2006 to 2011 (excluding 2009) was week
25 and the median week of the end of influenza season
was week 44. The median duration of the influenza
season was 21 weeks.
We observed that within the influenza season de-
scribed above, there was more than one peak of in-
creased proportion of influenza positive cases (Fig. 2). In
2006, using the 4-week moving average, three peaks
were seen. The first peak was higher than the other
peaks. Dual peaks were clearly distinct for 2007, 2008
and 2011. 2010 also had a minor second peak, which
could only be detected by looking at the bar graph.
Starting 2008 up to 2011, we observed minor peaks dur-
ing the first 11 weeks of the year. However these were
just single or two consecutive weeks of increased weekly
influenza positive rates.
Seasonal and alert threshold, and epidemic curve
Figure 3 shows the non-aligned and aligned transmission
peaks of influenza activity from 5 years of surveillance
data.
Figure 4 shows the plot of percent of cases for 2012
compared to the seasonal threshold (5%), average epi-
demic curve and alert threshold. The first 2 weeks of
2012 showed weekly influenza positivity rates which
were higher than the alert threshold followed by weekly
influenza positivity rates that were lower than the sea-
sonal threshold but only up to week 29 when influenza
season started, 8 weeks after the expected week of rise
of cases in week 21. The intensity was severe going
above the average epidemic curve but of short duration.
There was a sharp drop of weekly influenza positivity
rates after week 30 lower than the alert threshold but
still above the seasonal threshold. Thereafter, a minor
peak was observed in week 35 conforming to the dual
peak pattern observed for the other years. The decrease
in the percentage of weekly influenza positivity rates
below the seasonal threshold was sustained until week
40 with another small peak occurring in week 46.
Figure 5 Panel A shows that influenza A(H1) was the
dominant subtype in 2006, 2009, and 2011, influenza B in
2008 and 2010, and A(H3) in 2007. In this panel, from
2009 to 2011, the red H1N1 bar includes both seasonal
and pandemic influenza. Panel B shows that the periods
or peaks of increased activity observed during an influenza
season were each populated by distinctive influenza
strains, either a single dominant or co-circulating strains.
Two influenza B lineages were found for all years except
2009 although lineage of many influenza B strains could
not be determined for this year.
Comparison of circulating influenza strains and vaccine
strains
Ninety-two percent of SH vaccine strains matched that
of the circulating strains in 2006, compared to only 69%
for NH strains. This was also observed in 2008 (69%
versus 15.12%), and 2010 (66% versus 37%). Percent
matched strains were lowest in 2009 (the pandemic year)
with both SH and NH at 10.18% (Table 3).
Discussion
In this study we have established the seasonal and alert
thresholds, and average epidemic curve based on 5 years
of influenza surveillance data using the method de-
scribed in the WHO surveillance manual [1], described
the seasonality of influenza in the Philippines, and pre-
sented the influenza strains circulating in the country
from 2006 to 2011. While influenza viruses were de-
tected year-round, increased activity was seen from June
to November. We used the established thresholds and
epidemic curve to assess the influenza season for 2012,
its onset and end, and its severity in relation to these
thresholds. We also showed that intensity of influenza
activity was different for each year, and that different
strains of influenza viruses circulated every year. Ana-
lysis of influenza activity using weekly detections showed
more than one peak of activity within the influenza
season from June to November of each year. Different
dominant strains were associated with each peak.
Two influenza B lineages circulated for five out of six
surveillance years. Circulating strains matched the
Southern Hemisphere vaccine more often than
Northern Hemisphere vaccine strains.
The WHO surveillance manual has emphasized the
need for standardized tools to establish thresholds and
epidemic curves that could be used to compare influ-
enza season between countries, and to assess the severity
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Fig. 2 Plot of confirmed weekly influenza positivity rates from 2006 to 2011, National Influenza Surveillance, Philippines
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of the current season in a country to previous seasons of
that same country. The method recommended in the
manual [1] is relatively simple and uses software, which
is readily available, and can be implemented by NICs as
long as five or more years of influenza surveillance data
are available. Knowing the usual baseline level of disease
and the seasonal pattern as a point of reference aids in
determining whether the current season is atypical both
in timing and relative severity compared to previous
ones. This information can help improve the accuracy of
clinical diagnosis, appropriate use of antiviral medica-
tion, and the uptake and timeliness of seasonal influenza
vaccines. As of this writing, we have not seen studies in
Southeast Asia reporting established alert and seasonal
thresholds or epidemic curves using the WHO surveil-
lance manual. Although there is one publication from
Thailand wherein Early Aberration Reporting System
(EARS) and Cumulative sum (CUSUM) were used,
calculations were only for ILI [22]. Routine influenza
weekly monitoring reports from surveillance activities in
Asia included ILI and influenza strains but compared
these to historical influenza activity [23]. We have not
been able to obtain information from countries in Asia
on the use of the WHO method or moving epidemic
method (MEM) to establish influenza seasonal thresh-
olds or epidemic curves. At this point in time, there are
already many countries in Asia, which have more than
5 years of surveillance data. The WHO method for
calculating thresholds and epidemic curves could very
well be applied in these countries.
The Philippines, Bangladesh, Cambodia, India, the Lao
People’s Democratic Republic, Thailand and Vietnam
have similar influenza seasonality [5]. Seasonality has
been associated not only with climatological but also
latitudinal variations [5, 24–26]. Influenza virus infection
was found throughout the year in these countries, but
more than 60% of influenza positivity rates were ob-
served during the months of June to November [5]. The
capital cities of these countries lie north of the equator
(between 11.6 to 28.7° N). Thus, April to May is the
most appropriate month for influenza vaccination for
the Philippines and countries with similar seasonality
[5]. In areas in India north of 30° N however, there was
also increased influenza activity during winter, so that
a separate vaccination timing has been recommended
[5, 24, 25] for this country. In contrast, tropical countries
in Asia below 11° N like Indonesia (Jakarta, 6.2° N),
Malaysia (Kuala Lumpur, 3.2° N), and Singapore (1.3° N),
influenza was found all throughout the year with no dis-
tinct influenza season [5]. Specific analysis on the associ-
ation between influenza activity and climate variables has
not been done in this study but June to November coin-
cides with the rainy season in the Philippines similar to
that of Cambodia [27], Myanmar [28], North Thailand
[29], Bangladesh [5, 30], Lao [31], and some parts of India
South of Srinagar [24, 25]. Factors other than the rainy
season might also play a role for the increased influenza
virus activity starting the month of June in the Philippines.
Schools open in June for all levels in the Philippines, sug-
gesting the effect of crowding on influenza transmission.
More than one peak of influenza activity was observed
during the surveillance years but these peaks were
confined to the defined influenza season from June to
November. The presence of the different dominant in-
fluenza strains for each of the peaks may be through the
following mechanisms: virus interaction leading to inter-
ference between viruses, break in transmission due to
school vacation, development of immunity to the dom-
inant virus, or a combination of these factors. Goldstein
et al. [32] have noted that there was a negative associ-
ation between strains’ incidences indicating that high in-
fection rates with one strain can interfere with the
transmission of other strains. Raoult [33] has postulated
that the dynamics of influenza virus subtypes against
those of other subtypes and even other respiratory vi-
ruses is complex and interference between these viruses
might impact on their transmissibility in humans. School
closure has been associated with reduced transmission of
influenza virus because of decreased contact rate [34, 35].
School vacation or semestral break occurs at around the
end of October to the first week of November. We have
observed that influenza activity decreases during this time







2006 24 (Jun 11–17) 48 (Nov 26–Dec 2) 25 29 (Jul 16–Jul 22)
2007 25 (Jun 17–23) 43 (Oct 21–27) 19 27 (Jul 1–7)
2008 25 (Jun 15–21) 41 (Oct 5–11) 17 30 (Jul 20–26)
2010 24 (Jun 13–19) 44 (Oct 31–Nov 6) 21 33 (Aug 15–21)
2011 31 (Jul 31–Aug 6) 52 (Dec 25–31) 22 33 (Aug 14–20)
Median (week) 25 44 21 30
Range 24–31 41–52 17–25 27–33
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of school disruption. A break in the transmission of the
first peak dominant virus causes co-circulating influenza
strains to increase in activity leading to the development
of a second peak. Increased transmission of the first dom-
inant influenza strain may later lead to development of
sufficient immunity among the population, which in turn
will stop or decrease the spread of the virus. Consequently
increased activity of co-circulating strains [36, 37] occurs.
The influenza strains circulating in the Philippines
from 2006 to 2011 frequently matched the Southern ra-
ther than the Northern Hemisphere vaccine strains. The
vaccine currently used in the Philippines is the Southern
Table 3 Comparison of Northern and Southern Hemisphere vaccine strains with the circulating strains per year of observation
(2006–2011)
Northern Hemisphere vaccine strains % Matching
Circulating strains
Southern Hemisphere vaccine strains % Matching
Circulating strains
2005–2006 2006
A/New Caledonia/20/99 (H1N1)-like 45 A/New Caledonia/20/99 (H1N1)-like 45






Total Matching 69 Total Matching 92
aA/New York/55/2004(H3N2)-like virus was a circulating virus and was antigenically similar to A/California/7/2004-(H3N2)-like
2006–2007 2007
A/New Caledonia/20/99 (H1N1)-like 34 A/New Caledonia/20/99 (H1N1)-like 34
A/Wisconsin/67/2005 (H3N2)-likea 3 A/Wisconsin/67/2005 (H3N2)-likea 3
B/Malaysia/2506/2004-like 2 B/Malaysia/2506/2004-like 2
Total matching 39 Total matching 39
2007–2008 2008
A/Solomon Islands/3/2006 (H1N1) like 0 A/Solomon Islands/3/2006 (H1N1) like 0
A/Wisconsin/67/2005 (H3N2)-like 0.12 A/Brisbane/10/2007 (H3N2)-likea 14
B/Malaysia/2506/2004-like (VICTORIA lineage) 15 B/Florida/4/2006-like (YAMAGATA)b 55
Total matching 15.12 Total matching 69
aA/Brisbane/59/2007(H1N1)-like virus (one of the H3N2 circulating strains) is not antigenically similar to A/Solomon Islands/3/2006 (H1N1)-like virus;
bB/Shanghai Yamagata lineage (circulating strain) is antigenically similar to B/Florida/4/2006-like virus
2008–2009 2009
A/Brisbane/59/2007 (H1N1)-likea 1 A/Brisbane/59/2007 (H1N1)-likea 1
A/Brisbane/10/2007 (H3N2)-like 9 A/Brisbane/10/2007 (H3N2)-like 9
B/Florida/4/2006-like 0.18 B/Florida/4/2006-like 0.18
Total Matching 10.18 Total Matching 10.18
aA(H1N1) pdm09 was the H1N1 circulating virus for 2009
2009–2010 2010
A/Brisbane/59/2007 (H1N1)-like 0 A/California/7/2009 (H1N1)-likea 29
A/Brisbane/10/2007 (H3N2)-like 0 A/Perth/16/2009 (H3N2)-like 0
B/Brisbane/60/2008-like virus 37 B/Brisbane/60/2008-like 37
Total Matching 37 Total Matching 66
aA/California/7/2009 (H1N1)-like is antigenically similar to A(H1N1) pdm09 which is a circulating virus
2010 - 2011 2011
A/California/7/2009 (H1N1)-like 53 A/California/7/2009 (H1N1)-like 53
A/Perth/16/2009 (H3N2)-like 4 A/Perth/16/2009 (H3N2)-like 4
B/Brisbane/60/2008-likea 6 B/Brisbane/60/2008-like 6
Total Matching 63 Total Matching 63
aB/Malaysia/2506/2004-like (Victoria lineage) another circulating strain is antigenically similar to B/Brisbane/60/2008-like
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Hemisphere vaccine. Influenza B strains both of the
Yamagata and the Victoria lineages were found during
the years of surveillance. With these findings, the appro-
priate timing of vaccination should be from April to
May, the current choice of Southern Hemisphere influ-
enza vaccine should be continued, and most importantly,
the vaccine should contain two influenza B lineages.
Therefore, quadrivalent rather than trivalent vaccines
would be a better choice.
There are several limitations to this study. The first limi-
tation is that we used collated data from all sentinel sites to
analyze seasonality. Sixty-four percent of influenza positive
cases came from Luzon where Manila is located, 15% from
the Visayas islands, and 21% from Mindanao. Since major-
ity of the cases came from the Luzon islands, the results
may be representative for only the north of the Philippines.
The actual latitudinal location of the country extends from
5 to 20° N. Mindanao islands are situated below 9.7° N up
to 5° N. The second limitation is that we were not able to
compare the WHO method to other analytic methods. The
third limitation is that data from this study mostly came
from the pediatric age group (<15 years of age). There were
very few adult ILI consultations probably because adults
are able to handle ILI much better than children. The
Fig. 3 Weekly influenza positivity rates with transmission peaks of influenza activity aligned and not aligned
Fig. 4 Plot of average epidemic curve, alert and seasonal thresholds and weekly influenza positivity rates for year 2012, National Influenza
Surveillance, Philippines
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fourth limitation is that we could only match vaccine and
circulating strains through names of the strains detected
and not by genomic sequencing or antigenic testing. Al-
though the Philippine National Surveillance followed the
CDC definition for ILI, the definition of ILI was different
from other countries and this may be considered a fifth
limitation. Despite these limitations, this study has given a
valuable insight into the measurement of seasonal and alert
thresholds, and epidemic curves that will help DOH influ-
enza program managers in the management of annual in-
fluenza epidemics in the country.
Conclusions
Analysis of surveillance data from 2006 to 2012 has pro-
vided information about seasonal thresholds, epidemic
curves, and circulating strains to guide health personnel
in the control of influenza virus infection. Although in-
fluenza virus circulated throughout the year, a distinct
seasonality was observed from June to November. The
ideal time therefore to administer Southern Hemisphere
influenza vaccines is from April to May. Quadrivalent
vaccine might have more impact on influenza control
than trivalent vaccine. Policy-makers are now capable of
assessing the intensity or severity of the current influ-
enza epidemic even early in its course, and plan more
precisely resources necessary to control the outbreak. In-
fluenza surveillance activities should be continued in the
Philippines and funding for such activities should
already be incorporated into the Philippine health
budget. The results of seasonality patterns will be of im-
mense help in the analysis of future studies on excess
mortality during influenza seasons in the Philippines.
Continuation of surveillance activities is needed not only
to obtain data on circulating strains but also to recalcu-
late the thresholds and epidemic curves as influenza
surveillance continues. More sentinel sites should be
added in the Mindanao islands. If possible, a separate
analysis for seasonality is conducted for the Mindanao
area. Further research should be conducted on the
association of meteorological and other factors on sea-
sonality of influenza virus infection. Genomic sequen-
cing and antigenic testing of Philippine influenza virus
isolates should be conducted to determine more accur-
ately matching of vaccine and circulating strains.
Fig. 5 Panel a: Percentage of influenza subtypes from 2006 to 2011, National Influenza Surveillance, Philippines, Panel b: Circulating influenza
strains from 2006 to 2011, National Influenza Surveillance, Philippines
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